开放式生物技术：需要许可证。 - Suppr

Suppr

超能文献

Open biotechnology: licenses needed.

作者信息

Joly Yann

机构信息

Centre of Genomics and Policy, McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada.

出版信息

Nat Biotechnol. 2010 May;28(5):417-9. doi: 10.1038/nbt0510-417.

DOI:10.1038/nbt0510-417

PMID:20458301

Abstract

摘要

相似文献

Open biotechnology: licenses needed.

Nat Biotechnol. 2010 May;28(5):417-9. doi: 10.1038/nbt0510-417.

Supreme Court boosts licensees in biotech patent battles.

Nat Biotechnol. 2007 Mar;25(3):264-5. doi: 10.1038/nbt0307-264. Epub 2007 Mar 1.

When the human genome project and state street collide.

Nat Biotechnol. 2000 Sep;18(9):1009-10. doi: 10.1038/79281.

Biotechnology--a challenge to the patent system.

Curr Opin Biotechnol. 2004 Jun;15(3):254-7. doi: 10.1016/j.copbio.2004.04.004.

Genomics, proteomics and patents.

Trends Biotechnol. 2000 Oct;18(10):405-6. doi: 10.1016/s0167-7799(00)01494-3.

Compulsory licenses as a defense in pharmaceutical and biotech patent litigation.

Pharm Pat Anal. 2016 Sep;5(6):351-353. doi: 10.4155/ppa-2016-0035. Epub 2016 Nov 2.

Who deserves the patent pot of gold?: an inquiry into the proper inventorship of patient-based discoveries.

DePaul J Health Care Law. 2004 Spring;7(2):185-243.

Patent prosecution strategies for biotechnological inventions.

Assay Drug Dev Technol. 2004 Dec;2(6):697-702. doi: 10.1089/adt.2004.2.697.

Companies of all sizes are prospecting for proteins.

Nature. 2000 Apr 6;404(6778):684-6. doi: 10.1038/35007267.

The changing marketplace of bioinformatics.

Nat Biotechnol. 2000 Dec;18(12):1247-9. doi: 10.1038/82351.

引用本文的文献

Drug licensing as evidence of evolution, diffusion and catch-up in East Asia.

Nat Biotechnol. 2023 Feb;41(2):189-192. doi: 10.1038/s41587-023-01659-1.

Bio-inspired 3D microenvironments: a new dimension in tissue engineering.

Biomed Mater. 2016 Mar 4;11(2):022001. doi: 10.1088/1748-6041/11/2/022001.

Stem cell research funding policies and dynamic innovation: a survey of open access and commercialization requirements.

Stem Cell Rev Rep. 2014 Aug;10(4):455-71. doi: 10.1007/s12015-014-9504-5.

Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA).

Curr Pharmacogenomics Person Med. 2011 Dec 1;9(4):243-251. doi: 10.2174/187569211798377153.

Open science versus commercialization: a modern research conflict?

Genome Med. 2012 Feb 27;4(2):17. doi: 10.1186/gm316.

Theory of knowledge and biotech patents: worlds apart?

Nat Biotechnol. 2011 Nov 8;29(11):977-8. doi: 10.1038/nbt.2026.

本文引用的文献

Prepublication data sharing.

Nature. 2009 Sep 10;461(7261):168-70. doi: 10.1038/461168a.

The stem-cell market - patents and the pursuit of scientific progress.

N Engl J Med. 2007 Jun 7;356(23):2341-3. doi: 10.1056/NEJMp068256.

Evidence and anecdotes: an analysis of human gene patenting controversies.

Nat Biotechnol. 2006 Sep;24(9):1091-4. doi: 10.1038/nbt0906-1091.

Effects of patents and licenses on the provision of clinical genetic testing services.

J Mol Diagn. 2003 Feb;5(1):3-8. doi: 10.1016/S1525-1578(10)60444-8.

European-wide opposition against the breast cancer gene patents.

Eur J Hum Genet. 2002 Dec;10(12):783-5. doi: 10.1038/sj.ejhg.5200924.

Will a smaller genome complicate the patent chase?

Science. 2001 Feb 16;291(5507):1194. doi: 10.1126/science.291.5507.1194.

Organs for sale? Propriety, property, and the price of progress.

Public Interest. 1992 Spring(107):65-86.

Can patents deter innovation? The anticommons in biomedical research.

Science. 1998 May 1;280(5364):698-701. doi: 10.1126/science.280.5364.698.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Open biotechnology: licenses needed.

Nat Biotechnol. 2010 May;28(5):417-9. doi: 10.1038/nbt0510-417.

Supreme Court boosts licensees in biotech patent battles.

Nat Biotechnol. 2007 Mar;25(3):264-5. doi: 10.1038/nbt0307-264. Epub 2007 Mar 1.

When the human genome project and state street collide.

Nat Biotechnol. 2000 Sep;18(9):1009-10. doi: 10.1038/79281.

Biotechnology--a challenge to the patent system.

Curr Opin Biotechnol. 2004 Jun;15(3):254-7. doi: 10.1016/j.copbio.2004.04.004.

Genomics, proteomics and patents.

Trends Biotechnol. 2000 Oct;18(10):405-6. doi: 10.1016/s0167-7799(00)01494-3.

Compulsory licenses as a defense in pharmaceutical and biotech patent litigation.

Pharm Pat Anal. 2016 Sep;5(6):351-353. doi: 10.4155/ppa-2016-0035. Epub 2016 Nov 2.

Who deserves the patent pot of gold?: an inquiry into the proper inventorship of patient-based discoveries.

DePaul J Health Care Law. 2004 Spring;7(2):185-243.

Patent prosecution strategies for biotechnological inventions.

Assay Drug Dev Technol. 2004 Dec;2(6):697-702. doi: 10.1089/adt.2004.2.697.

Companies of all sizes are prospecting for proteins.

Nature. 2000 Apr 6;404(6778):684-6. doi: 10.1038/35007267.

The changing marketplace of bioinformatics.

Nat Biotechnol. 2000 Dec;18(12):1247-9. doi: 10.1038/82351.

引用本文的文献

Drug licensing as evidence of evolution, diffusion and catch-up in East Asia.

Nat Biotechnol. 2023 Feb;41(2):189-192. doi: 10.1038/s41587-023-01659-1.

Bio-inspired 3D microenvironments: a new dimension in tissue engineering.

Biomed Mater. 2016 Mar 4;11(2):022001. doi: 10.1088/1748-6041/11/2/022001.

Stem cell research funding policies and dynamic innovation: a survey of open access and commercialization requirements.

Stem Cell Rev Rep. 2014 Aug;10(4):455-71. doi: 10.1007/s12015-014-9504-5.

Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA).

Curr Pharmacogenomics Person Med. 2011 Dec 1;9(4):243-251. doi: 10.2174/187569211798377153.

Open science versus commercialization: a modern research conflict?

Genome Med. 2012 Feb 27;4(2):17. doi: 10.1186/gm316.

Theory of knowledge and biotech patents: worlds apart?

Nat Biotechnol. 2011 Nov 8;29(11):977-8. doi: 10.1038/nbt.2026.

本文引用的文献

Prepublication data sharing.

Nature. 2009 Sep 10;461(7261):168-70. doi: 10.1038/461168a.

The stem-cell market - patents and the pursuit of scientific progress.

N Engl J Med. 2007 Jun 7;356(23):2341-3. doi: 10.1056/NEJMp068256.

Evidence and anecdotes: an analysis of human gene patenting controversies.

Nat Biotechnol. 2006 Sep;24(9):1091-4. doi: 10.1038/nbt0906-1091.

Effects of patents and licenses on the provision of clinical genetic testing services.

J Mol Diagn. 2003 Feb;5(1):3-8. doi: 10.1016/S1525-1578(10)60444-8.

European-wide opposition against the breast cancer gene patents.

Eur J Hum Genet. 2002 Dec;10(12):783-5. doi: 10.1038/sj.ejhg.5200924.

Will a smaller genome complicate the patent chase?

Science. 2001 Feb 16;291(5507):1194. doi: 10.1126/science.291.5507.1194.

Organs for sale? Propriety, property, and the price of progress.

Public Interest. 1992 Spring(107):65-86.

Can patents deter innovation? The anticommons in biomedical research.

Science. 1998 May 1;280(5364):698-701. doi: 10.1126/science.280.5364.698.